144Filing Date: Aug 26, 2026

Edwards Lifesciences (EW)

Insider Proposed Sale Notice

View SEC Filing
ACC: 0001921094-26-000958

Sale Plan

Chopra Daveen
Officer·Edwards Lifesciences
Proposed
CommonNYSE
Shares31.80K
Est. DateAug 26
Market Value$2.89M
BrokerCharles Schwab & Co., Inc.
AcquisitionEmployee Stock Option Exercise · EDWARDS LIFESCIENCES CORPORATION
Acquired DateAug 26, 2026
Amount Acquired31.80K
% Outstanding0.0055%
Exercise / Payment Details
Paid: Aug 26, 2026Method: Broker Payment for Cashless Exercise
No sales in the past 3 months
Signature & Compliance expand_more
Notice DateAug 26, 2026
Signature Daveen Chopra
Issuer Info expand_more
CompanyEdwards Lifesciences Corp
CIK0001099800
SEC File No.001-15525
Phone9492502500
AddressONE EDWARDS WAY, IRVINE, CA 92614

keid analysis is for reference only and does not constitute investment advice.